NDA for FibroGen's anemia treatment accepted

07:27 EST 12 Feb 2020 | SmartBrief

FibroGen announced that the FDA has accepted the new drug application it submitted for roxadustat as a treatment for chronic  -More

Original Article: NDA for FibroGen's anemia treatment accepted


More From BioPortfolio on "NDA for FibroGen's anemia treatment accepted"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...